mortality/aging
• mutants exhibit an average lifespan of 242 days
(J:177632)
|
growth/size/body
weight loss
(
J:177632
)
• mutants start to lose weight at around 8 months of age
|
homeostasis/metabolism
• 8-fold decrease in plasma ATP concentrations
• 9-fold decrease in plasma pyrophosphate concentrations
• however, no differences in plasma phosphorus or calcium levels are seen
|
• at 8 months of age, heterozygotes show a decrease in serum glucose concentrations
|
• 29.5% higher levels of plasma alkaline phosphatase activity than controls
|
cellular
• mutants show nuclear abnormalities due to progerin accumulation
(J:177632)
• MEFs have more misshapen nuclei with nuclear blebs than wild-type MEFs
(J:177575)
|
cardiovascular system
• medial calcification in aortic arch and thoracic aorta at 30-34 weeks of age
|
• primary cultures of vascular smooth muscle cells from aortic tissue show a lower capacity to inhibit calcium deposition than control cells when incubated in calcifying medium
• aortic vascular smooth cells exhibit impaired capacity to synthesize extracellular pyrophosphate, show lower levels of extracellular ATP and intracellular ATP indicating impaired ATP synthesis, and have a lower COX:CS ratio indicating impaired mitochondrial function
|
muscle
• primary cultures of vascular smooth muscle cells from aortic tissue show a lower capacity to inhibit calcium deposition than control cells when incubated in calcifying medium
• aortic vascular smooth cells exhibit impaired capacity to synthesize extracellular pyrophosphate, show lower levels of extracellular ATP and intracellular ATP indicating impaired ATP synthesis, and have a lower COX:CS ratio indicating impaired mitochondrial function
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
progeria | DOID:3911 |
OMIM:176670 |
J:211388 |